These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
1331 results:

  • 1. [Non-small cell lung carcinoma with co-expression of TTF1 and p40: a clinicopathological analysis of six cases].
    Liu HS; Zhang YJ; Huang B; Ge HY; Cai LB; Chen MM
    Zhonghua Bing Li Xue Za Zhi; 2024 Nov; 53(11):1111-1116. PubMed ID: 39482048
    [No Abstract]    [Full Text] [Related]  

  • 2. Concurrent egfr mutation and SMARCA4 deficiency in non-small cell lung cancer: A case report and literature review.
    Dai W; Li T; Li Y; Chen C; Zhang X; Zhou P; Qi B
    Medicine (Baltimore); 2024 Oct; 103(41):e40081. PubMed ID: 39465834
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical characteristics and prognostic factors of epidermal growth factor receptor-mutated non-small cell lung cancer transformed into small-cell lung cancer after treatment].
    Zheng H; Zhao D; Gu M; Wang QH; Li CH; Li X; Li J; Che NY; Hu Y
    Zhonghua Yi Xue Za Zhi; 2024 Oct; 104(40):3751-3756. PubMed ID: 39463369
    [No Abstract]    [Full Text] [Related]  

  • 4. Targeting
    Liu H; Qin J; Qian X
    Cancer Control; 2024; 31():10732748241292782. PubMed ID: 39417568
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Pulmonary sarcomatoid carcinoma:report of three cases].
    Wang ZX; Wang YM; Shen YQ; Wu YM; Wang N; Ren XX; Zhang XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Oct; 47(10):960-964. PubMed ID: 39406543
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of COVID-19 infection in patients with NSCLC receiving egfr-TKI targeted therapy during the first wave in China.
    Huang P; Liao LM; Zhao JL; Luo C; Yi YL; Chen Y; Huang L
    J Int Med Res; 2024 Oct; 52(10):3000605241281907. PubMed ID: 39387199
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression.
    Fan Z; Shuai H
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113172. PubMed ID: 39298823
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Assessing the Sensitivity of Nested PCR Followed by Direct Sequencing on Exosomal DNA for egfr Mutation Detection in NSCL.
    Jahani MM; Mashayekhi P; Omrani MD; Khosravi A; Ali D; Azad Manjiri S; Zahraei M; Mabani M; Seifi S; Salimi B; Rostami P
    Iran Biomed J; 2024 Jul; 28(4):208-15. PubMed ID: 39289877
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.
    Xitlally PN; Alejandro AS; Norma HP; Mario OM; Enrique CP; Cesar CR; José LL; Pedro BB; Juan-Manuel HM; Oscar A
    J Transl Med; 2024 Sep; 22(1):841. PubMed ID: 39267111
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Potential therapeutic option for egfr-mutant small cell lung cancer transformation: a case report and literature review.
    Li X; Luan X; Zhang M; Wang R; Guo J; Lv J; Qiu W; Zhao S
    Front Immunol; 2024; 15():1439033. PubMed ID: 39234244
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival.
    Foresi B; Shah A; Meade S; Krishnaney A
    Eur Spine J; 2024 Nov; 33(11):4346-4352. PubMed ID: 39223432
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multimodal radiomics-based methods using deep learning for prediction of brain metastasis in non-small cell lung cancer with
    Zhu Y; Cong S; Zhang Q; Huang Z; Yao X; Cheng Y; Liang D; Hu Z; Shao D
    Biomed Phys Eng Express; 2024 Sep; 10(6):. PubMed ID: 39214122
    [No Abstract]    [Full Text] [Related]  

  • 13. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)].
    Oncology Society of Chinese Medical Association
    Zhonghua Yi Xue Za Zhi; 2024 Sep; 104(34):3175-3213. PubMed ID: 39193605
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune-inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD-L1 ≥50% metastatic non-small cell lung cancer receiving first-line immunotherapy.
    Zheng X; Zhou L; Shi H; An J; Xu W; Ding X; Hua Y; Shi W; Li X
    Thorac Cancer; 2024 Oct; 15(28):2029-2037. PubMed ID: 39189250
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Whole-Exome Sequencing and Experimental Validation Unveil the Roles of TMEM229A Q200del Mutation in lung Adenocarcinoma.
    Liang YX; Xie YP; Yu HM; Zhu WJ; Yin CY; Dong ZH; Zhang XL
    Clin Respir J; 2024 Aug; 18(8):e70006. PubMed ID: 39188060
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Strong PD-L1 affect clinical outcomes in advanced NSCLC treated with third-generation egfr-TKIs.
    Niu J; Jing X; Xu Q; Liu H; Tian Y; Yang Z; Zhu H; Sun Y
    Future Oncol; 2024; 20(32):2481-2490. PubMed ID: 39155845
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Non-small cell lung cancer with Metachronous Mutations of egfr and ALK Genes: 
A Case Report and Literature Review].
    Kong X; Wang M; Tang Q; Sun M; Hu J
    Zhongguo Fei Ai Za Zhi; 2024 Jul; 27(7):559-564. PubMed ID: 39147711
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer.
    Tamiya A; Osuga M; Harada D; Isa SI; Taniguchi Y; Nakamura K; Mizumori Y; Shinohara T; Yanai H; Nakatomi K; Oki M; Mori M; Kuwako T; Yamazaki K; Tamura A; Ando M; Koh Y
    Lung Cancer; 2024 Sep; 195():107917. PubMed ID: 39116552
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Landscape of Concomitant Driver Alterations in Classical
    Wang H; Lin L; Liang C; Pang J; Yin JC; Zhang J; Shao Y; Sun C; Guo R
    JCO Precis Oncol; 2024 Aug; 8():e2300520. PubMed ID: 39102631
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Construction of a nomogram model based on biomarkers for liver metastasis in non-small cell lung cancer.
    Zhang T; Zhang Y; Ni Y; Jia X; Li Y; Mao Z; Jiang P; Fu X; Jiao M; Jiang L; Wang W; Guo H; Zan Y; Liu M
    Thorac Cancer; 2024 Sep; 15(26):1897-1911. PubMed ID: 39098998
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 67.